0.82 (1.06%)Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Cosmo Pharmaceuticals NV
Telephone
353.1.8170370
Address
Sir John Rogerson's Quay, Riverside II, Dublin 2
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 53.3 - 129.6
Trade Value (12mth)
US$162,253.00
1 week
2.38%
1 month
-18.76%
YTD
-26.12%
1 year
44.24%
All time high
180.21
EPS 3 yr Growth
-120.10%
EBITDA Margin
2.20%
Operating Cashflow
-SFr11m
Free Cash Flow Return
-2.30%
ROIC
-0.70%
Interest Coverage
12.90
Quick Ratio
6.80
Shares Outstanding (Fully Diluted)
16m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
24-Apr-26
Next Dividend Pay Date
11-May-26
Reporting Currency
CHF
Short Sell (% of issue)
0.00
Historical data
Forecast data
| 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | GBP |  | | | | -0.65 | 7.76 | -0.21 | | | | ||
EPS (Fully Diluted) | GBP | | | | | -0.65 | 7.73 | -0.21 | | | | ||
Growth | % | | | | | -161.8 | 1,292.7 | -102.7 | | | | ||
PE | X | | | | | N/A | 8.2 | N/A | | | | ||
EV/EBITDA | X | | | | | 99.8 | 6.1 | 718.3 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
